Evidence map›Paper›PMID 37583580›Full record

ArticleFrontiers in cardiovascular medicine2023

Sumra Komal, Atia Gohar, Saad Althobaiti, Ishtiaq Ahmad Khan, Liu-Gen Cui, Li-Rong Zhang, Sheng-Na Han, Muhammad Shakeel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. The Role of NMedComm · 2026
    Review
  2. Article
  3. Review
  4. Role of the mInternational journal of molecular medicine · 2025
    Review
  5. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  6. Review
  7. Epitranscriptomic Regulations in the Heart.Physiological research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sumra Komal *Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Atia Gohar *Dow Institute for Advanced Biological and Animal Research, Dow University of Health Sciences, Karachi, Pakistan.
Saad AlthobaitiKing Faisal Medical Complex (KFMC), Taif, Saudi Arabia.
Ishtiaq Ahmad KhanJamil-ur-Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Liu-Gen CuiDepartment of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Li-Rong ZhangDepartment of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Sheng-Na HanDepartment of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Muhammad ShakeelJamil-ur-Rahman Center for Genome Research, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Zhengzhou University · CNDow University of Health Sciences · PKInternational Center for Chemical and Biological Sciences · PKUniversity of Karachi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart Failure (HF) is a complex clinical syndrome in which the heart is unable to provide enough blood flow to meet metabolic needs and lacks efficient venous return. HF is a major risk factor for morbidity and mortality with cardiovascular diseases globally. Despite enormous research, the molecular markers relevant to disease prognosis and management remain not well understood. Here, we analyzed the whole transcriptomes of 18 failing hearts and 15 non-failing hearts (predominantly of Caucasian origin), by applying the standard

Indexed as

AlkB homolog 5epitranscriptomicsheart failureN6-methyladenosinetranscriptome

Identifiers

PMID37583580
PMCPMC10425272
OpenAlexW4385411648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.